Showing results (1241-1250 of 3,791) with videos related to
Sort By:
Pageof 380
Oncoimmunology|November 20, 2012
High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytesLudovic Martinet, Sophie Le Guellec, Thomas Filleron, et al.Oncoimmunology|November 20, 2012
Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentationAlison M McDonnell, Andrew J Currie, Matthew Brown, et al.Oncoimmunology|November 20, 2012
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)Jennifer D Stone, David H Aggen, Andrea Schietinger, et al.Oncoimmunology|November 20, 2012
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapyErika Vacchelli, Lorenzo Galluzzi, Alexander Eggermont, et al.Oncoimmunology|November 20, 2012
TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosisTsukasa Seya, Hiroaki Shime, Hiromi Takaki, et al.Oncoimmunology|November 20, 2012
The antigen specific composition of melanoma tumor infiltrating lymphocytes?Sine Reker HadrupOncoimmunology|November 20, 2012
How two sites of inflammation promote carcinogenesis: The role of macrophages in inflammation associated carcinogenesisSusanne Sebens, Heiner SchäferOncoimmunology|November 20, 2012
New insights on the role of CD8(+)CD57(+) T-cells in cancerRichard C Wu, Patrick Hwu, Laszlo G RadvanyiOncoimmunology|November 20, 2012
Monoclonal antibody (mAb)-based cancer therapy: Is it time to reevaluate dosing strategies?Margaret A Lindorfer, Adrian Wiestner, Clive S Zent, et al.Oncoimmunology|November 20, 2012
DNA methylation markers for breast cancer prognosis: Unmasking the immune componentSarah Dedeurwaerder, François FuksPageof 380